Equities

Shockwave Medical Inc

Shockwave Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)330.13
  • Today's Change-0.75 / -0.23%
  • Shares traded1.03m
  • 1 Year change+19.28%
  • Beta1.0709
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 16-May-24
Select bar for recommendation details.
Recommendations16-May-24
Buy0
Outperform0
Hold11
Underperform0
Sell0

Share price forecast in USD

The 9 analysts offering 12 month price targets for Shockwave Medical Inc have a median target of 335.00, with a high estimate of 348.42 and a low estimate of 250.00. The median estimate represents a 1.48% increase from the last price of 330.13.
High5.5%348.42
Med1.5%335.00
Low-24.3%250.00

Earnings history & estimates in USD

On May 06, 2024, Shockwave Medical Inc reported 1st quarter 2024 earnings of 1.44 per share. This result exceeded the 0.98 consensus of the 11 analysts covering the companyand exceeded last year's 1st quarter results by 39.81%.
The next earnings announcement is expected on Aug 05, 2024.
Average growth rate+11.27%
Shockwave Medical Inc reported annual 2023 earnings of 3.85 per share on Feb 15, 2024.
Average growth rate+20.50%
More ▼

Revenue history & estimates in USD

ShockWave Medical, Inc. had 1st quarter 2024 revenues of 218.81m. This bettered the 207.69m consensus of the 10 analysts covering the company. This was 35.85% above the prior year's 1st quarter results.
Average growth rate+8.01%
ShockWave Medical, Inc. had revenues for the full year 2023 of 730.23m. This was 49.11% above the prior year's results.
Average growth rate+115.84%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.